This panel featured Dr. Thomas Hutson, Dr. Saby George, Dr. Jeff Yorio, and Louise Gunter. Hutson: You all can jump in as you would like to. But the first question is, does immunotherapy affect other ...

Please provide your email address to receive an email when new articles are posted on . An FDA panel voted that for adults with uncontrolled hypertension, the benefits of an ultrasound renal ...

Adding cystatin C to serum creatinine testing better-identified patients at risk for end-stage kidney disease and all-cause death, new study findings indicate. “Our results suggest that a ...

Please provide your email address to receive an email when new articles are posted on . An FDA panel voted that for adults with uncontrolled hypertension, the benefits of a radiofrequency renal ...

This panel was moderated by Kristie L. Kahl and featured Dr. Thomas Hutson, Louise Gunter and Meryl Uranga. Kahl: I want to shift gears to talk about side effects and dose reductions. So Louise, I ...

Standardizing follow-up after kidney stone treatment may reduce ionizing radiation exposure, identify recurrences earlier, and avoid complications such as urosepsis and chronic kidney disease, ...

Silver Spring, MD - A US Food and Drug Administration advisory panel is generally in agreement that at least two gadolinium contrast dyes, gadodiamide (Omniscan, GE Healthcare) and gadoversetamide ...

An expert panel of US nephrologists and other health care providers unanimously agreed that secondary hyperparathyroidism treatment is often started too late in patients with chronic kidney disease. A ...

A radiofrequency-based renal denervation system for uncontrolled hypertension got a cool reception from FDA advisors who nevertheless left the door open for regulatory approval. On Wednesday, the ...

The US Food and Drug Administration's (FDA's) Circulatory System Devices Panel unanimously agreed that the Symplicity Spyral Renal Denervation System (Medtronic, Inc.) is safe, but the panel was split ...